Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: The tumor suppressor protein PML controls apoptosis induced by the HIV-1 envelope.

Cell death and differentiation·2026
Same author

Editorial Expression of Concern: The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis.

Cell death and differentiation·2026
Same author

From asking to observing. Behavioural measures of socio-emotional and motivational skills in large-scale assessments.

Social science research·2023
Same author

Melanoma secretion of transforming growth factor-β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration.

The British journal of dermatology·2021
Same author

Performance decline in a low-stakes test at age 15 and educational attainment at age 25: Cross-country longitudinal evidence.

Journal of adolescence·2021
Same author

[Erratum to: Diagnosis at first sight].

Der Radiologe·2021

Related Experiment Video

Updated: May 18, 2026

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens
13:45

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens

Published on: April 27, 2011

Applying proteomic technology to clinical virology.

C Mancone1, F Ciccosanti2, C Montaldo1

  • 1'Lazzaro Spallanzani' National Institute for Infectious Diseases I.R.C.C.S.; Department of Cellular Biotechnologies and Haematology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome.

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|October 5, 2012
PubMed
Summary

Proteomics, a powerful technology, aids in developing antiviral drugs and vaccines by analyzing host-virus interactions. This review highlights its use in understanding viral persistence and pathogenicity, especially for hepatitis C.

More Related Videos

Profiling of Surface Protein Epitopes on Viral Particles by Multiplex Dual-Reporter Strategy
08:07

Profiling of Surface Protein Epitopes on Viral Particles by Multiplex Dual-Reporter Strategy

Published on: January 12, 2024

Identification of Protein Interacting Partners Using Tandem Affinity Purification
10:02

Identification of Protein Interacting Partners Using Tandem Affinity Purification

Published on: February 25, 2012

Related Experiment Videos

Last Updated: May 18, 2026

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens
13:45

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens

Published on: April 27, 2011

Profiling of Surface Protein Epitopes on Viral Particles by Multiplex Dual-Reporter Strategy
08:07

Profiling of Surface Protein Epitopes on Viral Particles by Multiplex Dual-Reporter Strategy

Published on: January 12, 2024

Identification of Protein Interacting Partners Using Tandem Affinity Purification
10:02

Identification of Protein Interacting Partners Using Tandem Affinity Purification

Published on: February 25, 2012

Area of Science:

  • Virology
  • Proteomics
  • Biochemistry

Background:

  • Developing antiviral drugs, vaccines, and diagnostics remains a key challenge in clinical virology.
  • High-throughput technologies have accelerated the development of antiviral strategies and translational research.
  • Preclinical virology studies focus on host-virus protein interactions, their composition, and localization.

Purpose of the Study:

  • To review the utility of proteomic approaches in studying viral persistence and pathogenicity.
  • To highlight recent advances in applying proteomics to hepatitis C virus (HCV) research.

Main Methods:

  • Mass spectrometry-based proteomics is a key method for analyzing protein composition in subcellular compartments.
  • Proteomics enables quantification of differential protein expression between samples.
  • Techniques include characterization of protein complexes and analysis of post-translational modifications.

Main Results:

  • Proteomics provides deep insights into host-virus interactions crucial for drug and vaccine development.
  • The review synthesizes current knowledge on proteomic applications in virology.
  • Specific examples from hepatitis C research illustrate the power of these methods.

Conclusions:

  • Proteomics is an increasingly vital tool in virology research, significantly impacting the study of viral diseases.
  • Understanding protein dynamics through proteomics advances the development of novel antiviral therapies.
  • Further application of proteomic strategies, particularly in hepatitis C, promises to enhance our ability to combat viral infections.